This systematic review examines the implementation of machine learning and deep learning architectures to predict drug-drug interactions specifically involving anticancer medications. Because oncology patients frequently require polypharmacy, they face a heightened risk of adverse events or reduced treatment efficacy caused by complex biochemical interferences. The researchers analyzed 59 studies ...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动